MGMT and central nervous system cancer: We included PANoptotic cluster and clinical characteristics, such as age, histology, IDH mutation, 1p/19q co-deletion, and MGMT promoter methylation into multivariate Cox regression analysis and found that PANoptotic cluster is an independent factor affecting the prognosis of glioma patients (Supplementary Figure S2A).